Heart disease in women is the main focus of all our research. The research involves international partnerships in Italy, Germany and USA. Different projects focus on heart disease due to high blood pressure, obesity, autoimmune diseases and aortic valve stenosis. Our research has so far contributed to the publication of European recommendations for treatment of high blood pressure in patients with aortic valve stenosis (2020) and a strong international focus on sex differences in heart disease through scientific publications, reviews and position papers in high-end journals including European Heart Journal, Nature Medicine and Hypertension. A new Centre for research on heart disease in women was established at UiB in June 2020 supported by Hjertefondet, Bergen Sanitetskvinner/Norske Kvinners Sanitetsforening and Grieg Foundation (https://www.uib.no/en/femaleheart). Our future research will be integrated with this new network. Furthermore in 2024 a new Center on Women's Health will be opende in May, and our research will we integrated also with this new, broader initiative on women's health.

The third survey in the Hordaland Health Study (HUSK3) was performed from June 2018 until June 2022. The main focus is to explore the impact of change in blood pressure and other health factors when the participants were in their forties for cardiovascular health 20 years later. The HUSK3 project is a collaboration between 4 research groups at UiB chaired by Eva Gerdts, Grethe S. Tell, Ottar Nygård and Jutta Dierkes, the BEVITAL academic laboratory and professor Marjolein Iversen at the Western Norway University of Applied Sciences. Additional information may be found under: PhD student Ester A. Kringeland, UiB; PhD student Zoya Sabir, UiB; PhD student Annabel E. Ohldieck, UiB

Uncontrolled high blood pressure is a major health challenge in Norway and a focus area for my research, in particular related to sex differences in how high blood pressure promote damage to the heart. From 2019 we participate in a new research collaboration between the 4 Norwegian Medical Faculties in Bergen, Oslo, Trondheim and Tromsø focusing on mechanisms for uncontrolled high blood pressure among patients who use blood pressure lowering drug treatment. This IDA study is funded by the Norwegian Research Council. At campus, we have also developed a local collaboration with consultant PhD Marianne Grytaas, Section for endocrinology, Haukeland University Hospital, Bergen, to study mechanisms of heart damage in patients with primary aldosteronism, a common cause of uncontrolled high blood pressure. In particular these studies will explore whether high blood pressure associated heart damage differs between women and men or depending on the etiology. See information on: PhD student Arleen Aune, UiB

Women with autoimmune diseases represent a high-risk group for development of premature heart disease. A research program on heart disease in autoimmune disorders have been developed in collaboration with national and international partners. From 2018 a research collaboration with Department of Rheumatology, Haukeland University Hospital has focused on the cardiac benefit of modern immunomodulating therapy for rheumatoid arthritis.  See information on: Senior researcher PhD Helga Midtbø, UiB and Haukeland University Hospital and PhD student Anja G. Linde

A program targeting preclinical heart disease in young patients with ischemic stroke was initiated in 2010 in collaboration with professor Ulrike Waje-Andreassen, Department of Neurology, Haukeland University Hospital. The follow-up examinations were completed in 2022. The program also includes an engagement from the Helsinki University Hospital to serve as echocardiography core laboratory in the European multicenter study SECRETO in patients who suffer a cryptogenic stroke before the age of 50 years. See also PhD fellow Rune Eilertsen, UiB, associate professor Dana Cramariuc, UiB and research student Rasmus Bach Sindre, UiB.

 

 

https://www.vg.no/nyheter/innenriks/i/l3zqWL/fersk-rapport-kvinner-har-dobbelt-saa-stor-risiko-for-hjerteinfarkt-naar-blodtrykket-stiger

Nasjonalforeningen awarded the 2022 Cardiac Research Prize to Eva Gerdts. The award was presented by King Harald of Norway

https://forskning.no/demens-forskningspriser-hjernen/kongen-delte-ut-forskningspriser/2018501 

ESC Council on hypertension video on Hypertension in Women for May month of Hypertension 2024

ESC Council on Hypertension (escardio.org)

At the UiB: I give thematic lectures on hypertension, hemodynamics, hypertensive heart disease, heart failure with preserved ejection fraction, all in a sex and gender perspective.

I am also contributing to a hands on course in handheld echocardiography using the VScan device. See course leader Helga Midtbø, UiB for further details.

At the UiO: I give an annual lecture about sex differences in heart disease

Academic article

• Barbara M. Hulsen; Janneke P. Spiegelenberg; Nicolas Martinez-Majander et al. (2026). Preceding Infections and Coagulation Biomarkers in Early-Onset Cryptogenic Ischemic Stroke. (external link)
• Sofie Abels; Maximillian Sihvo; Liisa Tomppo et al. (2026). Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke. (external link)
• Jale Moradi; Ellen Berggreen; Eva Gerdts et al. (2026). Taxonomic and functional signatures of smoking and periodontitis severity in the subgingival microbiome of older adults. (external link)
• Anja Linde; Eva Gerdts; Bjørg Tilde Svanes Fevang et al. (2025). Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart study. (external link)
• Jukka Putaala; Nicolas Martinez-Majander; Michelle Leppert et al. (2025). Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale. (external link)
• Nina Jaakonmäki; Tuukka Helin; Timea Szanto et al. (2025). Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke. (external link)
• Lucas Lauder; Thomas Weber; Michael Böhm et al. (2025). European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice. (external link)
• Rune Krogh Eilertsen; Helga Bergljot Midtbø; Beenish Adeel Chaudry Nawaz et al. (2025). Associations of short-term blood pressure variability with presence and progression of organ damage over five years in ischaemic stroke survivors: the Norwegian Stroke in the Young Study. (external link)
• K Wachtell; Eva Gerdts; V Palmieri et al. (2010). In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. (external link)
• Costantino Mancusi; Maria Angela Losi; Raffaele Izzo et al. (2019). Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network. (external link)
• Sahrai Saeed; Ulrike Waje-Andreassen; Mai Tone Lønnebakken et al. (2016). Covariates of non-dipping and elevated night-time blood pressure in ischemic stroke patients: the Norwegian Stroke in the Young Study. (external link)
• Sahrai Saeed; Eva Gerdts; Ulrike Waje-Andreassen et al. (2019). Left ventricular myocardial dysfunction in young and middle-aged ischemic stroke patients: the Norwegian stroke in the young study. (external link)
• Giovanni Cioffi; Giovanni de Simone; Dana Cramariuc et al. (2012). Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. (external link)
• Eva Gerdts; Ester Anne Kringeland; Helga Bergljot Midtbø (2022). Hjertesykdom er vanlig – også hos kvinner. (external link)
• Mai Tone Lønnebakken; Gottfried Greve; Elisabeth Leirgul et al. (2008). Brain abscess caused by paradoxical embolization in Ebstein's anomaly. (external link)
• Rune Krogh Eilertsen; Helga Bergljot Midtbø; Rasmus Bach Sindre et al. (2024). Factors associated with progression of arterial stiffness in ischemic stroke survivors: the Norwegian Stroke in the Young Study. (external link)
• Eigir Einarsen; Dana Cramariuc; Mai Tone Lønnebakken et al. (2017). Comparison of frequency of ischemic cardiovascular events in patients with aortic stenosis with versus without asymmetric septal hypertrophy (from the SEAS Trial). (external link)
• Silvana Cicala; Giovanni de Simone; Eva Gerdts et al. (2010). Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. (external link)
• Vera Regitz-Zagrosek; Sabine Oertelt-Prigione; Eva Prescott et al. (2016). Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. (external link)
• Dana Cramariuc; Edda Bahlmann; Kenneth Egstrup et al. (2020). Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis. (external link)
• Peter M. Okin; Kristian Wachtell; Eva Gerdts et al. (2014). Relationship of levt ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the Development of New heart failure. (external link)
• K Wachtell; JN Bella; PR Liebson et al. (2000). Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. (external link)
• Mai Tone Lønnebakken; Terje H Larsen; Eva Gerdts et al. (2014). Iatrogenic external pudendal artery pseudoaneurysm with a communicating arteriovenous fistula - A diagnostic and therapeutic pitfall. (external link)
• GM Balarini; E Zandonade; L Tanure et al. (2016). Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.. (external link)
• Eva Gerdts; Giovanni de Simone; Barbara Patricia Lund et al. (2013). Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. (external link)
• Costantino Mancusi; Eva Gerdts; Maria Angela Losi et al. (2017). Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). (external link)
• Helga Bergljot Midtbø; Eva Gerdts; Tore Kristian Kvien et al. (2016). The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. (external link)
• Mai Tone Lønnebakken; Åshild Elseth Rieck; Eva Gerdts (2011). Contrast stress echocardiography in hypertensive heart disease. (external link)
• K Wachtell; G Smith; Eva Gerdts et al. (2000). Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (external link)
• Eva Gerdts; Einar Svarstad; Ole Landmark Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (external link)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2013). Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. (external link)
• Agata Bielecka-Dabrowa; Marta Michalska-Kasiczak; Anna Gluba et al. (2015). Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. (external link)
• Ola Undrum Bergland; Lene Vernås Halvorsen; Camilla Lund Søraas et al. (2021). Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations. (external link)
• Eva Gerdts; Raffaele Izzo; Costantino Mancusi et al. (2018). Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). (external link)
• Åshild Elseth Rieck; Eva Gerdts; Mai Tone Lønnebakken et al. (2012). Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). (external link)
• PM Okin; E Gerdts; Sverre Erik Kjeldsen et al. (2008). Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy in Response to Antihypertensive Therapy. (external link)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2011). Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). (external link)
• Hilde Espnes; Jocasta Ball; Maja-Lisa Løchen et al. (2021). Sex-specific associations between blood pressure and risk of atrial fibrillation subtypes in the tromsø study. (external link)
• Dana Cramariuc; Eva Gerdts; Johannes Just Hjertaas et al. (2015). Myocardial function in aortic stenosis - insights from radial multilayer Doppler strain. (external link)
• Bin Zhou; Mariachiara Di Cesare; Carlos A Aguilar-Salinas et al. (2024). General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. (external link)
• Eva Gerdts; Richard B. Devereux (2002). Sex differences in left ventricular systolic function. (external link)
• Arleen Aune; Annabel Eide Ohldieck; Lene Vernås Halvorsen et al. (2024). Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence. (external link)
• Johannes Just Hjertaas; Eigir Einarsen; Eva Gerdts et al. (2023). Impact of aortic valve stenosis on myocardial deformation in different left ventricular levels: A three-dimensional speckle tracking echocardiography study. (external link)
• Hager Rahmatalla Zein Elabdeen; Ellen Berggreen; Knut Helge Jensen et al. (2025). Prevalence of Periodontitis in a 70-Year-Old Population in Western Norway According to the ACES 2018 Classification Framework: A Cross-Sectional Study. (external link)
• Peter M. Okin; Eva Gerdts; Kristiana Wachtell et al. (2010). Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. (external link)
• Helga Bergljot Midtbø; Eva Gerdts; Tore Kristian Kvien et al. (2015). Disease activity and left ventricular structure in patients with rheumatoid arthritis. (external link)
• Eva Gerdts; Hans Bjørnstad; Sigurd Toft et al. (2002). Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). (external link)
• Giovanni Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2011). Left atrial systolic force in asymptomatic ortic stenosis. (external link)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2011). Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. (external link)
• Eva Gerdts; Lasse Oikarinen; Vittorio Palmieri et al. (2002). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. (external link)
• Eva Gerdts; JE Otterstad (2000). HOPE ett år senere. (external link)
• RB Devereux; MJ Roman; V Palmieri et al. (2000). Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. (external link)
• K Wachtell; JN Bella; PR Liebson et al. (2000). Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. (external link)
• R. B. Devereux; J. N. Bella; K. Boman et al. (2001). Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (external link)
• V. Papademetriou; R. B. Devereux; P. Narayan et al. (2001). Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study. (external link)
• Eva Gerdts; M. Zabalgoitia; H. Björnstad et al. (2001). Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). (external link)
• V. Palmieri; K. Wachtell; Eva Gerdts et al. (2001). Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. (external link)
• Mai Tone Lønnebakken; Eva Gerdts; Kurt Boman et al. (2011). In-treatment stroke volume predicts cardiovascular risk in hypertension. (external link)
• Henrik K. Thomassen; Giovanni Cioffi; Eva Gerdts et al. (2017). Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. (external link)
• Eva Gerdts; JE Otterstad (2000). HOPE ett år senere. (external link)
• RB Devereux; MJ Roman; V Palmieri et al. (2000). Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. (external link)
• Eva Gerdts; Kristian Wachtell; Per Omvik et al. (2007). Left atrial size and risk of major cardiovascular events during antihypertensive treatment - Losartan intervention for endpoint reduction in hypertension trial. (external link)
• Peter M. Okin; Richard B. Devereux; Eva Gerdts et al. (2006). Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy - The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. (external link)
• Jan Minners; Christa Gohlke-Baerwolf; Beat A. Kaufmann et al. (2014). Adjusting parameters of aortic valve stenosis severity by body size. (external link)
• Ingeborg Eskerud; Eva Gerdts; Jan Erik Nordrehaug et al. (2015). Global coronary artery plaque area is associated with myocardial hypoperfusion in women with non-ST elevation myocardial infarction. (external link)
• Morten Dalsgaard; Kenneth Egstrup; Kristian Wachtell et al. (2008). Left atrial volume in patients with asymptomatic aortic valve stenosis (the simvastatin and ezetimibe in aortic stenosis study). (external link)
• K Wachtell; G Smith; Eva Gerdts et al. (2000). Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (external link)
• Per Omvik; Eva Gerdts; O Myking et al. (1999). Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. (external link)
• Sahrai Saeed; Ulrike Waje-Andreassen; Annette Fromm et al. (2014). Early vascular aging in young and middle-aged ischemic stroke patients: The Norwegian stroke in the young study. (external link)
• J. N. Bella; K. Wachtell; V. Palmieri et al. (2001). Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. (external link)
• K Wachtell; B Hornestam; M Lehto et al. (2005). Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (external link)
• Annette Fromm; Lars Thomassen; Halvor Næss et al. (2013). The Norwegian stroke in the young study (NOR-SYS): rationale and design. (external link)
• Ingeborg Eskerud; Eva Gerdts; Terje H Larsen et al. (2019). Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study). (external link)
• Kristiana Wachtell; Eva Gerdts; Gerard P. Aurigemma et al. (2010). In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. (external link)
• T Melberg; Karel Kuiper; Eva Gerdts et al. (1999). Early complications and long-term mortality after urgent or routine coronary angioplasty. (external link)
• Nikolaus Jander; Christa Gohlke-Bärwolf; Edda Bahlmann et al. (2014). Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis. (external link)
• Arleen Aune; Marina Victorovna Kokorina; Marianne Aa. Grytaas et al. (2021). Preclinical cardiac disease in women and men with primary aldosteronism. (external link)
• K Wachtell; M Lehto; E Gerdts et al. (2005). Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (external link)
• Eva Gerdts; Dana Cramariuc; Giovanni de Simone et al. (2008). Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). (external link)
• Vittorio Palmieri; Peter M. Okin; Jonathan N. Bella et al. (2003). Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiograaphhic left ventricular hypertrophy The life study. (external link)
• Gerard P Aurigemma; Richard B. Devereux; Kristian Wachtell et al. (2003). Left ventricular mass regression in the life study: effect of previous antihypertensive treatment. (external link)
• Einar S Davidsen; Eva Gerdts (2003). Hjertesykdom ved genetisk hemokromatose. (external link)
• Vittorio Palmieri; Jonathan N. Bella; Mary J Roman et al. (2003). Pulse pressure/stroke index and left ventricular geometry and function:the Life Study. (external link)
• Mai Tone Lønnebakken; Raffaele Izzo; Costantino Mancusi et al. (2016). Aortic root dimension and arterial stiffness in arterial hypertension: The Campania Salute Network. (external link)
• Edda Bahlmann; Eva Gerdts; Eigir Einarsen et al. (2025). Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis. (external link)
• Mai Tone Lønnebakken; Øyvind Bleie; Elin Strand et al. (2009). Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. (external link)
• Barbara Rogge; Dana Cramariuc; Mai Tone Lønnebakken et al. (2013). Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis. (external link)
• Eva Gerdts; Stanley Franklin; Åshild E.Eidheim Elseth Rieck et al. (2009). Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study). (external link)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (external link)
• Edda Bahlmann; Christoph A. Nienaber; Dana Cramariuc et al. (2011). Aortic root geometry in aortic stenosis patients (a SEAS substudy). (external link)
• Mai Tone Lønnebakken; Eva Gerdts; Jan Wirsching et al. (2009). Ultrasound in evaluation of post-interventional femoral vein obstruction: a case report. (external link)
• Eva Gerdts; Anne Bjørhovde Rossebø; Terje Rolf Pedersen et al. (2015). Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. (external link)
• Silvana Cicala; Richard B. Devereux; Giovanni de Simone et al. (2007). Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2019). Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study. (external link)
• Sahrai Saeed; Eva Gerdts; Ulrike Waje-Andreassen et al. (2019). Searching for explanations for cryptogenic stroke in the young: Revealing the Etiology, Triggers, and outcome (SECRETO): Echocardiography performance protocol. (external link)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2020). Left ventricular myocardial oxygen demand and subclinical dysfunction in patients with severe obesity referred for bariatric surgery. (external link)
• Jukka Putaala; Nicolas Martinez-Majander; Sahrai Saeed et al. (2017). Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. (external link)
• R.B. Devereux; K. Wachtell; Eva Gerdts et al. (2004). Prognostic significance of left ventricular mass change during treatment of hypertension. (external link)
• Eva Gerdts; Per Omvik; Rune Mo et al. (2004). Hypertensjon og hjertesykdom. (external link)
• Astrid Strandheim; Hilde Halland; Sahrai Saeed et al. (2015). Obesity-associated metabolic changes influence resting and peak heart rate in women and men. (external link)
• I. Os; S. Oparil; Eva Gerdts et al. (2004). Essential hypertension in women. (external link)
• R.B. Devereux; B. Dahlof; Eva Gerdts et al. (2004). Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol - The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. (external link)
• K. Wachtell; V. Papademetriou; G. Smith et al. (2004). Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. (external link)
• M.H. Olsen; K. Wachtell; J.N. Bella et al. (2004). Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. (external link)
• V Palmieri; K. Wachtell; J.N. Bella et al. (2004). Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. (external link)
• Eva Gerdts; Ole L. Myking; Per Omvik (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. (external link)
• Stian Ludvigsen; Costantino Mancusi; Simon Kildal et al. (2018). Cardiac adaptation to hypertension in adult female Dahl salt-sensitive rats is dependent on ovarian function, but loss of ovarian function does not predict early maladaptation. (external link)
• J. Kontos; V. Papademetriou; K. Wachtell et al. (2004). Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• Hilde Espnes; Tom Wilsgaard; Jocasta Ball et al. (2025). Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø Study. (external link)
• Edda Bahlmann; Dana Cramariuc; Sahrai Saeed et al. (2019). Low systemic arterial compliance is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis. (external link)
• Eva Gerdts; Lodve Stangeland; H. Engedal et al. (1994). Postoperative Doppler echocardiograpic evaluation in different sizes of Medtronic-Hall, Biocor and Carpentier-Edwards s.a.v. prosthetic-aortic valves. (external link)
• E.M. Staal; Ottar Nygård; Per Omvik et al. (2004). Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. (external link)
• J.N. Bella; V. Palmieri; K. Wachtell et al. (2004). Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. (external link)
• Z.B. Li; K. Wachtell; P.M. Okin et al. (2004). Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• M.H. Olsen; K. Wachtell; J.N. Bella et al. (2004). Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). (external link)
• Eva Gerdts; M.J. Roman; V. Palmieri et al. (2004). Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). (external link)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2010). Myocardial deformation in aortic valve stenosis – relation to left ventricular geometry. (external link)
• Marcus Lund Frølich; Einar Skulstad Davidsen; Mai Tone Lønnebakken et al. (2010). An unusual location of a papillary fibroelastoma. (external link)
• Eva Gerdts; Peter M. Okin; Giovanni de Simone et al. (2008). Gender differences in left ventricular structure and function during antihypertensive treatment - The Losartan intervention for Endpoint reduction in hypertension study. (external link)
• Ingrid Os; Veronica Franco; Sverre E. Kjeldsen et al. (2008). Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study. (external link)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2021). One-year impact of bariatric surgery on left ventricular mechanics: results from the prospective FatWest study. (external link)
• Joshua B Feinberg; Emil E Nielsen; Sverre Kjeldsen et al. (2023). Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study. (external link)
• Anja Linde; Eva Gerdts; Bjørg Tilde Svanes Fevang et al. (2024). Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study. (external link)
• Bernd Timmermann; Rune Mo; Friederich C Luft et al. (1998). Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. (external link)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Factors Influencing Left Ventricular Mass in Salt Sensitive and Salt Resistant Essential Hypertensive Patients. (external link)
• Cedric Davidsen; Terje H Larsen; Eva Gerdts et al. (2016). Giant right ventricular outflow tract thrombus in heriditary spherocytosis: a case report. (external link)
• Nadia Pristaj; Sahrai Saeed; Helga Bergljot Midtbø et al. (2020). Covariables of myocardial function in women and men with increased body mass index. (external link)
• Rasmus Bach Sindre; Eva Gerdts; Jukka Putaala et al. (2024). Association of Left Atrial Stiffness With Risk of Cryptogenic Ischemic Stroke in Young Adults. (external link)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Is salt sensitivity a temporary phenomenon?. (external link)
• Eva Gerdts; Sahrai Saeed; Helga Bergljot Midtbø et al. (2019). Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. (external link)
• Eirik Olsen; Lene Vernås Halvorsen; Stine Rognstad et al. (2025). Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study. (external link)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2016). Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• Mari Bergflødt Sørensen; Hanne Rosendahl-Riise; Kristin Øksendal Børresen et al. (2025). Low maternal iodine intake and subsequent risk of pharmacologically treated hypertension: A population-based prospective cohort study. (external link)
• Anders M. Greve; Michael Hecht Olsen; Jonathan N. Bella et al. (2012). Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: A LIFE study. (external link)
• Edda Bahlmann; Dana Cramariuc; Jan Minners et al. (2017). Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. (external link)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (external link)
• Anne B. Rossebø; AB Rossebo; Terje R. Pedersen et al. (2008). Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. (external link)
• Eva Gerdts; Gunnar Kvam; R Mo et al. (1998). The Bergen Blood pressure Study: changes in cardiac structure and function in offspring of hypertensive families. (external link)
• Eva Gerdts; Z Zabalgoitia; H Bjornstad et al. (1998). Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy. The LIFE. (external link)
• Eva Gerdts; Per Omvik; Per Lund-Johansen (1999). Reproducibility of salt sensitivity testing using a dictary approach in essential hypertension. (external link)
• Hilde Halland; Knut Matre; Eigir Einarsen et al. (2019). Effect of fitness on cardiac structure and function in overweight and obesity (the FATCOR study). (external link)
• Mai Tone Lønnebakken; Raffaele Izzo; Costantino Mancusi et al. (2017). Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network). (external link)
• Hilde Halland; Mai Tone Lønnebakken; Nadia Pristaj et al. (2018). Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). (external link)
• Mai Tone Lønnebakken; Marianne Staal; Øyvind Bleie et al. (2009). Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. (external link)
• Anja G Linde; Eva Gerdts; Kåre Steinar Tveit et al. (2021). Subclinical cardiac organ damage in patients with moderate to severe psoriasis. (external link)
• Grzegorz Piotrowski; Maciej Banach; Eva Gerdts et al. (2011). Left atrial size in hypertension and stroke. (external link)
• Annabel Eide Ohldieck; Helga Bergljot Midtbø; Ester Anne Kringeland et al. (2025). Stronger Association Between Blood Pressure and Arterial Stiffness in Older Women than Men: The Hordaland Health Study. (external link)
• Giovanni de Simone; Peter M. Okin; Eva Gerdts et al. (2009). Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. (external link)
• Åshild E.Eidheim Elseth Rieck; Dana Cramariuc; Eva Marianne Staal et al. (2010). Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). (external link)
• Marcello Chinali; Gerard P Aurigemma; Giovanni de Simone et al. (2009). Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy). (external link)
• Dana Cramariuc; Giovanni Cioffi; Åshild E.Eidheim Elseth Rieck et al. (2009). Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. (external link)
• Giovanni Cioffi; Tiziano Edoardo Russo; Carlo Stefenelli et al. (2010). Severe obstructive sleep apnea elicits concentric left ventricular geometry. (external link)
• Gyda Ullensvang; Ester Anne Kringeland; Eirik Ikdahl et al. (2023). Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis. (external link)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2018). Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis. (external link)
• Åshild Oftedal; Eva Gerdts; Ulrike Waje-Andreassen et al. (2018). Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study. (external link)
• Edda Bahlmann; Eigir Einarsen; Dana Cramariuc et al. (2022). Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area. (external link)
• Eva Gerdts; Anne Bjørhovde Rossebø; Terje Rolf Pedersen et al. (2010). Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study). (external link)
• Eva Gerdts; Hans Bjørnstad; Richard B. Devereux et al. (2006). Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). (external link)
• Nikolaus Jander; Jan Minners; Ingar Morten K Holme et al. (2011). Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. (external link)
• Sahrai Saeed; Roxy Senior; Navtej S. Chahal et al. (2017). Lower transaortic flow rate is Associated with increased mortality in aortic valve stenosis. (external link)
• Mai Tone Lønnebakken; Giovanni de Simone; Sahrai Saeed et al. (2017). Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. (external link)
• Giovanni Cioffi; Eva Gerdts; Dana Cramariuc et al. (2010). Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases. (external link)
• Lene Vernås Halvorsen; Camilla Lund Søraas; Anne Cecilie Kjeldsen Larstorp et al. (2024). Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial. (external link)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Marianne Staal et al. (2008). Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). (external link)
• Jannike Øyen; Anne Lise Brantsæter; Lene Secher Myrmel et al. (2025). Maternal intake of dietary protein from plant and animal sources and development of pharmacologically treated hypertension within 10 years after pregnancy. (external link)
• Giovanni Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2012). Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis. (external link)
• Nicolaus Jander; Willibald Hochholzer; Beat A. Kaufmann et al. (2014). Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. (external link)
• Arleen Aune; Eva Gerdts; Marina Victorovna Kokorina et al. (2022). Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. (external link)
• Ingar Morten K Holme; Terje Rolf Pedersen; Kurt Boman et al. (2012). A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. (external link)
• Jonathan N. Bella; Kristian Wachtell; Kurt Boman et al. (2002). Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). (external link)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2012). Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis the SEAS (Simvastatin and Ezetimibe in aortic stenosis) study. (external link)
• Mai Tone Lønnebakken; Costantino Mancusi; Mari Angela Losi et al. (2019). Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network. (external link)
• Janet Joy Kachuchuru Lutale; Hrafnkell Thordarson; Zulfiqarali Gulam-Abbas et al. (2008). Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania. (external link)
• Per Omvik; Eva Gerdts; Ole L. Myking et al. (2000). Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. (external link)
• Eigir Einarsen; Sahrai Saeed; Dana Cramariuc et al. (2019). Impact of obesity on persistent left Ventricular hypertrophy after aortic valve replacement for aortic stenosis. (external link)
• Kristian Wachtell; Jonathan N. Bella; Jens Rokkedal et al. (2002). Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. (external link)
• Kristian Wachtell; Vittorio Palmieri; Michael Hecht Olsen et al. (2002). Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study. (external link)
• Barbara Rogge; Eva Gerdts; Dana Cramariuc et al. (2014). Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. (external link)
• Casper N. Bang; Eva Gerdts; Gerard P. Aurigemma et al. (2014). Four-group classifcation of left ventricular hypertrophy based on ventricular concentricity and dilatation identifes a low-risk subset of eccentric hypertrophy in hypertensive patients. (external link)
• Eva Gerdts (2002). Bruk av ekkokardiografi i hypertensjonsstudier. (external link)
• Richard B. Devereux; Vittorio Palmieri; Jennifer E. Liu et al. (2002). Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study. (external link)
• Kristian Wachtell; Vittorio Palmieri; Michael Hecht Olsen et al. (2002). Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. (external link)
• Eva Gerdts; Vasilios Papademetriou; Vittorio Palmieri et al. (2002). Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). (external link)
• Annabel Eide Ohldieck; Ester Anne Kringeland; Helga Bergljot Midtbø et al. (2023). High-normal blood pressure in midlife is a stronger risk factor for incident hypertension 26 years later in women than men: the Hordaland Health Study. (external link)
• Hilde Halland; Mai Tone Lønnebakken; Sahrai Saeed et al. (2017). Does fitness improve the cardiovascular risk profile in obese subjects?. (external link)
• Costantino Mancusi; Helga Bergljot Midtbø; Nicola De Luca et al. (2021). Association of myocardial energetic efficiency with circumferential and longitudinal left ventricular myocardial function in subjects with increased body mass index (The fatcor study). (external link)
• Marina De Marco; Eva Gerdts; Costantino Mancusi et al. (2017). Influence of left ventricular stroke volume on incident heart failure in a population with preserved ejection fraction (from the Strong Heart Study). (external link)
• G De Simone; PM Okin; E Gerdts et al. (2009). Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. (external link)
• Einar Skulstad Davidsen; Knut Liseth; Per Omvik et al. (2007). Reduced exercise capacity in genetic haemochromatosis. (external link)
• Christa Gohlke-Bärwolf; Jan Minners; Nicolaus Jander et al. (2013). Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. (external link)
• Silvia Damiano; Marina De Marco; Federica del Genio et al. (2012). Effect of bariatric surgery on left ventricular geometry and function in severe obesity. (external link)
• Morten Dalsgaard; Kenneth Egstrup; Kristian Wachtell et al. (2013). Left atrial volume as predictor of valve replacement and cardiovascular events in patients with asymptomatic mild to moderate aortic stenosis. (external link)
• Ester Anne Kringeland; Eva Gerdts; Arve Ulvik et al. (2022). Inflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland Health Study. (external link)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2021). Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. (external link)
• Edda Bahlmann; Eva Gerdts; Dana Cramariuc et al. (2013). Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis. (external link)
• Pilly Mussa Chillo; Johnson Lwakatare; Åshild Elseth Rieck et al. (2014). Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. (external link)
• Casper N. Bang; Eva Gerdts; Gerard P. Aurigemma et al. (2013). Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. (external link)
• Jon Andreas Bratberg; Efraim Bulut; Åshild Elseth Rieck et al. (2014). Determinants of systolic blood pressure response during exercise in overweight subjects. (external link)
• Richard B. Devereux; Casper N. Bang; Mary J. Roman et al. (2015). Left ventricular wall stress-mass-heart rate product and cardiovascular events in treated hypertensive patients: Life study. (external link)
• Anja G Linde; Eva Gerdts; Ulrike Waje-Andreassen et al. (2018). Covariables and types of abnormal left ventricular geometry in nonelderly ischemic stroke survivors: The Norwegian Stroke in theYoung Study. (external link)
• Gianfranco Parati; Alexandra Goncalves; David Soergel et al. (2023). New perspectives for hypertension management: progress in methodological and technological developments. (external link)
• Marina De Marco; Eva Gerdts; Giuseppina Casalnuovo et al. (2013). Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: The LIFE study. (external link)
• Hanna Augedal Os; Silvia Christin Hellerud Rollefstad; Eva Gerdts et al. (2020). Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. (external link)
• Nina Kovac; Lisa Marie Dale Grymyr; Eva Gerdts et al. (2022). Markers of Subclinical Atherosclerosis in Severe Obesity and One Year after Bariatric Surgery. (external link)
• Dana Cramariuc; Barbara Rogge; Mai Tone Lønnebakken et al. (2015). Sex differences in cardiovascular outcome during progression of aortic valve stenosis. (external link)
• Ekaterina Sharashova; Eva Gerdts; Jocasta Ball et al. (2025). Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromsø Study. (external link)
• Dana Cramariuc; Giovanni Cioffi; Åshild Elseth Rieck et al. (2009). Low-Flow Aortic Stenosis in Asymptomatic Patients Valvular-Arterial Impedance and Systolic Function From the SEAS Substudy. (external link)
• Yuan Lu; Kaveh Hajifathalian; Majid Ezzati et al. (2013). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. (external link)
• Ingeborg Eskerud; Eva Gerdts; Terje Hjalmar Larsen et al. (2021). Total coronary atherosclerotic plaque burden is associated with myocardial ischemia in non-obstructive coronary artery disease. (external link)
• Isabel Eva Kenny; Sahrai Saeed; Eva Gerdts et al. (2017). Masked hypertension in obesity: Potential predictors and arterial damage. (external link)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2020). Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. (external link)
• Sergej Ostojic; Nowell H. Phelps; Rosie K. Singleton et al. (2024). Worldwide trends in the underweight and obesity from 1990 to 2022: a pooled analysis of 3,633 population-representative studies with 222 million school-aged children, adolescents, and adults. (external link)
• Nora Tuseth; Dana Cramariuc; Åshild E.Eidheim Elseth Rieck et al. (2010). Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). (external link)
• Sahrai Saeed; Ulrike Waje-Andreassen; Annette Fromm et al. (2016). Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study.. (external link)
• Eva Gerdts; Peter M. Okin; Per Omvik et al. (2009). Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. (external link)
• Dana Cramariuc; Eva Gerdts; Leidulf Segadal (2006). Impact of hypertension on left ventricular hypertrophy regression and exercise capacity in patients operated for aortic valve stenosis. (external link)
• Eigir Einarsen; Eva Gerdts; Ulrike Waje-Andreassen et al. (2020). Association of increased arterial stiffness with diastolic dysfunction in ischemic stroke patients the Norwegian Stroke in the Young Study. (external link)
• Jukka Putaala; Bettina von Sarnowski; Ulf Schminke et al. (2024). Association of Hypertension With Early-Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case-Control Study. (external link)
• Kurt Boman; Eva Gerdts; Kristian Wachtell et al. (2009). Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. (external link)
• Shakar Kutal; Lauri Juhani Tulkki; Tomi Sarkanen et al. (2025). Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults: A Case-Control Study. (external link)
• Helga Bergljot Midtbø; Arve Ulvik; Dana Cramariuc et al. (2024). Influence of cardiorespiratory fitness on obesity-associated inflammation in women and men: The FATCOR study. (external link)
• Eva Gerdts; Peter M. Okin; Kurt Boman et al. (2012). Association of heart failure hospitalizations with combined electrocardiography and ehocardiography criteria for left ventricular hypertrophy. (external link)
• Giuseppina Casalnuovo; Eva Gerdts; Giovanni de Simone et al. (2012). Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (The Campania Salute Network). (external link)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2014). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study). (external link)
• Peter M. Okin; Eva Gerdts; Sverre Erik Kjeldsen et al. (2008). Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy. (external link)
• Lisa Marie Dale Grymyr; Gunnar Mellgren; Adrian McCann et al. (2024). Preoperative risk factors associated with left ventricular dysfunction after bariatric surgery. (external link)
• John Glad Eikås; Eva Gerdts; Hilde Halland et al. (2023). Arterial Stiffness in Overweight and Obesity: Association with Sex, Age, and Blood Pressure. (external link)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1997). Angiotensin converting enzyme inhibition and alpha<SUB>1</SUB>-receptor blockade as antihypertensive therapy in type-1 diabetic patients. (external link)
• Nicolas Martinez-Majander; Shakar Kutal; Pauli Ylikotila et al. (2024). Association between heavy alcohol consumption and cryptogenic ischaemic stroke in young adults: A case-control study. (external link)
• Zeinab Bidel; Milad Nazarzadeh; Dexter Canoy et al. (2023). Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis. (external link)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (external link)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for months months. (external link)
• Silvana Cicala; Giovanni de Simone; Kristian Wachtell et al. (2008). Clinical impact of ' in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• Eigir Einarsen; Johannes Just Hjertaas; Haotian Gu et al. (2021). Impact of arterio-ventricular interaction on first-phase ejection fraction in aortic stenosis. (external link)
• Eva Gerdts (2008). Left ventricular structure in different types of chronic pressure overload. (external link)
• Eva Gerdts; O. L. Myking; Per Lund-Johansen et al. (1997). Regression of left ventricular hypertrophy in type-1 diabetic patients using doxazosin as antihypertensive therapy @<abstract@>. (external link)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1996). Factors influencing left ventricular mass in hypertensive type-1 diabetic patients. (external link)
• Einar Svarstad; Eva Gerdts; Per Omvik et al. (2001). Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. (external link)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (external link)
• Pilly Mussa Chillo; johnson lwakatare; Janet Joy Kachuchuru Lutale et al. (2012). Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients. (external link)
• Pilly Mussa Chillo; Åshild Elseth Rieck; Johnson Lwakatare et al. (2013). Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients. (external link)
• Eva Gerdts; Giovanni de Simone (2021). Hypertension in women: Should there be a sex-specific threshold?. (external link)
• Costantino Mancusi; Christian Basile; Eva Gerdts et al. (2024). Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients. (external link)
• Edda Bahlmann; Dana Cramariuc; Eva Gerdts et al. (2010). Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy. (external link)
• Helga Bergljot Midtbø; Ester Anne Kringeland; Eva Gerdts et al. (2022). Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. (external link)
• Marcello Chinali; Giovanni de Simone; Kristian Wachtell et al. (2008). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• Alexander Lilja-Cyron; Casper N. Bang; Eva Gerdts et al. (2022). Aortic root dilatation in hypertensive patients with left ventricular hypertrophy–application of a new multivariate predictive model. The Life Study. (external link)
• Katrine Tryti Lindseth; Eva Gerdts; Helga Bergljot Midtbø et al. (2023). Myocardial Work in Middle-Aged Adults with Overweight and Obesity: Associations with Sex and Central Arterial Stiffness. (external link)
• Asle Hirth; Nicola C. Edwards; Gottfried Greve et al. (2012). Left ventricular function in children and adults after renal transplantation in childhood. (external link)
• Einar Skulstad Davidsen; Per Omvik; Tor Hervig et al. (2009). Left ventricular diastolic function in patients with treated haemochromatosis. (external link)
• Mai Tone Lønnebakken; Jan Erik Nordrehaug; Eva Gerdts (2014). No gender difference in the extent of myocardial ischemia in non-ST elevation myocardial infarction. (external link)
• Edda Bahlmann; Eigir Einarsen; Dana Cramariuc et al. (2021). Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis. (external link)
• Pauli Pöyhönen; Jouni Kuusisto; Jani Pirinen et al. (2022). Orientation of the Atrial Septum to the Inferior Vena Cava May Contribute to the Persistent Patency of the Foramen Ovale. (external link)
• Pauli Pöyhönen; Jouni Kuusisto; Jani Pirinen et al. (2021). Right atrium and cryptogenic ischaemic stroke in the young: A case-control study. (external link)
• Maria-Angela Losi; Costantino Mancusi; Helga Bergljot Midtbø et al. (2019). Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. (external link)
• Helga Bergljot Midtbø; Eva Gerdts; Inger Jorid Berg et al. (2018). Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. (external link)
• Eigir Einarsen; Dana Cramariuc; Edda Bahlmann et al. (2021). Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis. (external link)
• Mai Tone Lønnebakken; Ingeborg Eskerud; Terje H Larsen et al. (2019). Impact of aortic stiffness on myocardial ischaemia in non-obstructive coronary artery disease. (external link)
• Kirsti Ytrehus; Stian Ludvigsen; Costantino Mancusi et al. (2021). Heart Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression Associated With Male Sex and Salt-Sensitive Hypertension in the Dahl Rat. (external link)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2016). Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. (external link)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2025). Long-Term Trajectories of Left Heart Geometry, Mechanics, and Oxygen Demand After Bariatric Surgery. (external link)
• Einar Skulstad Davidsen; Tor Hervig; Per Omvik et al. (2009). Left ventricular long-axis function in treated haemochromatosis. (external link)
• Kristian Wachtell; Vittorio Palmieri; Eva Gerdts et al. (2010). Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study). (external link)
• Giovanni Cioffi; Pompilio Faggiano; Enrico Vizzardi et al. (2011). Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. (external link)
• Eva Gerdts; E. Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (external link)
• Eran S. Zacks; Ildri Maria Stokke; Kristian Wachtell et al. (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypertensive patients. The LIFE Study. (external link)
• Marcello Chinali; Gerard P. Aurigemma; Eva Gerdts et al. (2022). Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study. (external link)
• Bertina Nielsen Herfindal; Eva Gerdts; Ester Anne Kringeland et al. (2020). Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. (external link)
• Anne B. Rossebø; Terje R. Pedersen; Christopher Allen et al. (2007). Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. (external link)
• Åshild Elseth Rieck; Dana Cramariuc; Kurt Boman et al. (2012). Hypertension in Aortic Stenosis Implications for Left Ventricular Structure and Cardiovascular Events. (external link)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. (external link)
• Ekaterina Sharashova; Eva Gerdts; Jocasta Ball et al. (2022). Sex-specific time trends in incident atrial fibrillation and the contribution of risk factors: the Tromsø Study 1994-2016. (external link)
• Mai Tone Lønnebakken; Eva Marianne Staal; Jan Erik Nordrehaug et al. (2011). Usefulness of contrast echocardiography for predicting the severity of angiographic coronary disease in non-ST-elevation myocardial infarction. (external link)
• Christa Gohlke-Bärwolf; Dana Cramariuc; Anne B. Rossebø et al. (2010). Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in aortic stenosis [SEAS] substudy). (external link)

Academic literature review

• Tijana Mitić; Adriana Georgescu; Nicoleta Alexandru-Moise et al. (2025). Current status and challenges of multi-omics research using animal models of atherosclerosis. (external link)
• Susana Novella; Eva Gerdts; Georgios Kararigas (2025). Divergent mechanisms of cardiovascular remodeling between men and women. (external link)
• Eva Gerdts; Susana Novella; Yvan Devaux et al. (2025). Biological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension. (external link)
• Dana Cramariuc; Eva Gerdts (2016). Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic. (external link)
• Eva Gerdts; Vera Regitz-Zagrosek (2019). Sex differences in cardiometabolic disorders. (external link)
• Costantino Mancusi; Giovanni de Simone; Jana Brguljan Hitij et al. (2020). Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (external link)
• Miron Sopic; Baiba Vilne; Eva Gerdts et al. (2023). Multiomics tools for improved atherosclerotic cardiovascular disease management. (external link)
• John William McEvoy; Cian P. McCarthy; Rosa Maria Bruno et al. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (external link)
• Eva Gerdts; Isabella Sudano; Sofie Brouwers et al. (2022). Sex differences in arterial hypertension. (external link)
• Cinzia Perrino; Péter Ferdinandy; Hans Erik Bøtker et al. (2021). Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: Position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. (external link)
• Costantino Mancusi; Edda Bahlmann; Christian Basile et al. (2022). New Evidence About Aortic Valve Stenosis and Cardiovascular Hemodynamics. (external link)
• Ingrid Os; S Oparil; E Gerdts et al. (2004). Essential hypertension in women. (external link)
• Valeria Valim; Eva Gerdts; Roland Jonsson et al. (2016). Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. (external link)
• Dana Cramariuc; Edda Bahlmann; Eva Gerdts (2022). Grading of Aortic Stenosis: Is it More Complicated in Women?. (external link)
• Sahrai Saeed; Eva Gerdts (2018). Managing complications of hypertension in aortic valve stenosis patients. (external link)
• Mai Tone Lønnebakken; Eva Gerdts (2010). Impact of ultrasound contrast agents in echocardiographic assessment of ischemic heart disease. (external link)
• Giovanni de Simone; Raffaele Izzo; Nicola De Luca et al. (2013). Left ventricular geometry in obesity: Is it what we expect?. (external link)

Other presentation

• Leonora Onarheim Bergsjø; Eva Gerdts; Tone Merete Norekvål (2025). Hjertehelse er ikke kjønnsnøytralt - kan e-helse bli det?. (external link)

Conference poster

• Hanne Flagtvedt; Ester Anne Kringeland; Christian Moltu et al. (2025). Kjønnsforskjeller i kardiovaskulære risikofaktorer og mental helse etter perkutan koronar intervensjon. (external link)
• Birgit Schulz; Anders Hervold; Stig Frode Samnøy et al. (2005). 3T MRI of patients with coronary artery disease. (external link)
• EA Kringeland; Grethe S. Tell; H Midtbo et al. (2019). Predictors and covariables of increase in systolic blood pressure in women and men over a 6-year period in midlife: the Hordaland Health Study. (external link)
• Vasilios Papademetriou; Kristian Wachtell; Eva Gerdts et al. (2003). Left ventricular mass changes in patients with isolated systolic or combined hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. (external link)
• Eva Staal; Per Omvik; Einar S Davidsen et al. (2003). Comparison of blood pressure measurements by the Keito machine to casual blood pressure measured by physicians. (external link)
• Kristian Wachtell; Vittorio Palmieri; Eva Gerdts et al. (2003). Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy: The LIFE study. (external link)
• Kurt Boman; Marie Olofsson; Bjørn Dahlöf et al. (2003). Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy: The LIFE study. (external link)
• Kristian Wachtell; Eva Gerdts; Vittorio Palmieri et al. (2003). Systolic left ventricular function improves more by beta-blockade than losartan: The LIFE study. (external link)
• Ziben Li; Richard B Devereux; Kristian Wachtell et al. (2003). Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: The LIFE study. (external link)
• Einar S Davidsen; Eva Gerdts (2003). reproduserbarhet av pulset vevs-Doppler målinger hos pasienter med hemokromatose. (external link)
• Eva Gerdts; Mary J Roman; Vittorio Palmieri et al. (2003). Older age does not attenuate hypertrophy regression during antihypertensive treatment in hypertensive patients with left ventricular hypertrophy. (external link)
• Mai Tone Lønnebakken; Øyvind Bleie; Elin Strand et al. (2007). Asessment of Coronary Artery Stenoses by Myocardial Contrast Stress Echocardiography. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2020). Sex-specific temporal trends in the incidence of atrial fibrillation in a large Norwegian population-based study 1986-2014. (external link)
• E Svarstad; Eva Gerdts; Per Omvik et al. (1995). Captopril and Doxazosin induce similar changes in renal hemodynamics in ambulatory hypertensive patients with insulin dependent diabetes mellitus (IDDM). (external link)
• Dana Cramariuc; Åshild Elseth Rieck; Giovanni Cioffi et al. (2011). Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. (external link)
• Merethe Visnes; Per Omvik; Sylvi Aanderud et al. (1999). Factors influencing cardiac hypertrophy in type-1 diabetes mellitus. (external link)
• Hilde Espnes; Jocasta Ball; Maja-Lisa Løchen et al. (2022). Risk factors and prognosis for heart failure in atrial fibrillation subtypes in women and men. (external link)

Conference abstract

• Zhibin Li; Kristian Wachtell; Sverre E. Kjeldsen et al. (2007). Association of aortic regurgitation with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: The LIFE study. (external link)
• Eva Gerdts; Dana Cramariuc; Åshild E.Eidheim Elseth Rieck et al. (2007). Pulse pressure - An independent predictor of left ventricular hyperthrophy in patients with asymptomatic aortic stenosis. A SEAS substudy. (external link)
• Peter M. Okin; Kristian Wachtell; Eva Gerdts et al. (2007). Relationship of left ventricular Systolic function to persistence or development,of Electrocardiographic left ventricular hypertrophy in hypertensive patients: Implications for the development of new heart failure. (external link)
• Raffaele Izzo; Giovanni de Simone; Valentina Trimarco et al. (2013). Hypertensive target organ damage predicts incident diabetes mellitus. (external link)
• Marcello Chinali; Rakesh K. Mishra; Giovanni de Simone et al. (2007). Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: The LIFE echo-substudy. (external link)
• Zhibin Li; Kristian Wachtell; Sverre E. Kjeldsen et al. (2007). Gender difference in the association of aortic valve sclerosis and cardiovascular events in hypertensive adults with left ventricular hypertrophy: The LIFE study. (external link)
• Dana Cramariuc; Johannes Just Hjertaas; Leidulf Segadal et al. (2011). Impact of aortic valve stenosis and hypertension on radial strain in multiple layers. (external link)
• Eva Gerdts; I Botta; G Cioffi et al. (2012). Covariates of global longitudinal strain and displacement in type 2 diabetes: a speckle tracking echocardiography study. (external link)
• John Glad Eikås; Eva Gerdts; Helga Bergljot Midtbø et al. (2022). SEX DIFFERENCES IN ARTERIAL FUNCTION IN OBESITY: THE FAT-ASSOCIATED CARDIOVASCULAR DYSFUNCTION STUDY. (external link)
• AE Rieck; Dana Cramariuc; Eva M Staal et al. (2009). ISOLATED SYSTOLIC HYPERTENSION IN PATIENTS WITH ASYMPTOMATIC AORTIC STENOSIS (A SEAS SUBSTUDY). (external link)
• PM Okin; Eva Gerdts; DA Hille et al. (2009). Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study. (external link)
• Giovanni Cioffi; Giovanni de Simone; Dana Cramariuc et al. (2009). Compensatory or inappropriate left ventricular mass in asymptomatic aortic stenosis. (external link)
• Dana Cramariuc; Giovanni Cioffi; Christa Golke-Bärwolf et al. (2009). Relation of degree of aortic valve calcification to left ventricular geometry and systolic function in asymptomatic aortic valve stenosis: A SEAS substudy. (external link)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2009). 2D Longitudinal Myocardial Strain: A More Sensitive Parameter of Left Ventricular Dysfunction in Aortic Valve Stenosis?. (external link)
• H Midtboe; Eva Gerdts; IC Olsen et al. (2013). Does rheumatoid arthritis predispose to abnormal left ventricular geometry independent of hypertension?. (external link)
• I Eskerud; Eva Gerdts; Jan Erik Nordrehaug et al. (2013). Coronary artery plaque burden is a predictor of myocardial ischemia in non-ST elevation myocardial infarction in both genders. (external link)
• Mai Tone Lønnebakken; Eva Gerdts; K Boman et al. (2009). IMPACT OF STROKE VOLUME ON CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (A LIFE SUBSTUDY). (external link)
• Jan Minners; Nikolaus Jander; Eva Gerdts et al. (2013). Outcome in 1763 asymptomatic patients with mild or moderate calcific aortic stenosis followed prospectively with annual echocardiography. (external link)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2013). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE). (external link)
• Eva Gerdts; Anne B. Rossebø; Terje R. Pedersen et al. (2009). Impact of severity of aortic valve stenosis on effect of intensive lipid-lowering therapy: The SEAS study. (external link)
• Eva Gerdts; Peter M. Okin; Giovanni de Simone et al. (2008). Gender differences in left ventricular structure and function during antihypertensive treatment (the LIFE study). (external link)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2008). The differential impact of static and pulsatile blood pressure components on regional myocardial deformation in patients with asymptomatic aortic valve stenosis. A SEAS substudy. (external link)
• Sverre Kjeldsen; Eran S. Zachs; Ildri Maria Stokke et al. (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypersensitive patients. (external link)
• Eva Gerdts; P. Okin; K. Wachtell et al. (2010). COMBINED USE OF ELECTROCARDIOGRAM AND ECHOCARDIOGRAM TO BETTER IDENTIFY HYPERTENSIVE PATIENTS AT HIGH RISK FOR HEART FAILURE. (external link)
• Giovanni de Simone; Peter M. Okin; Eva Gerdts et al. (2007). Does metabolic syndrome influence reduction of ECG left ventricular hypertrophy? The LIFE study. (external link)
• Marcello Chinali; Gerard P. Aurigemma; Peter M. Okin et al. (2009). Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substudy. (external link)
• P. Chillo; J. Lwakatare; Janet Joy Kachuchuru Lutale et al. (2010). Increased Relative Wall Thickness - A Frequent Marker of Subclinical Cardiac Target Organ Damage in African Diabetic Patients. (external link)
• Eva Gerdts; Dana Cramariuc; Mai Tone Lønnebakken et al. (2010). Left ventricular mass, an independent predictor of morbidity and mortality in aortic valve stenosis. (external link)
• Peter M. Okin; Eva Gerdts; Kristian Wachtell et al. (2006). Relationship of left atrial enlargement to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. (external link)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Marianne Staal et al. (2006). Prevalence and covariates of low left ventricular midwall shortening in patients with asymptomatic aortic valve stenosis. A SEAS substudy. (external link)
• Einar Skulstad Davidsen; Karel Kier-Jan Kuiper; Knut Matre et al. (2014). Determinants of left ventricular systolic function after transcatheter aortic valve implantation. (external link)
• Zoya Sabir; Jutta Dierkes; Anette Hjartåker et al. (2023). Dietary Intake And Adherence To Food-Based Dietary Guidelines In Older Norwegian Adults – The Hordaland Health Studies. (external link)
• N Jander; J Minners; I Holme et al. (2009). Outcome of Asymptomatic Patients With Low Gradient "Severe" Aortic Valve Stenosis and Preserved Ejection Fraction - Results From the Prospective SEAS Study. (external link)
• E.S. Davidsen; Eva Gerdts (2004). Tissue Doppler findings in patients with genetic hemochromatosis. (external link)
• K. Wachtell; V. Palmieri; Eva Gerdts et al. (2004). Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (external link)
• R.B. Devereux; K. Wachtell; Eva Gerdts et al. (2004). Ethnicity, left ventricular hypertrophy regressio and cardiovascular events in the LIFE echocardiography substudy. (external link)
• S. Donkor; S. Gordon; Per Omvik et al. (2004). Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in Ghana. (external link)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Staal et al. (2007). Impact of left ventricular geometry on stress-corrected left ventricular systolic function in asymptomatic aortic valve stenosis. A SEAS substudy. (external link)
• AE Rieck; D Cramariuc; E.M. Staal et al. (2005). Impact of concomitant hypertension on left ventricular structure in patients with aortic valve stenosis. The SEAS study. (external link)
• V. Palmieri; PM Okin; K. Wachtell et al. (2005). Relationship of electrocardiographic strain pattern to left ventricular diastolic function in hypertensive patients: The LIFE study. (external link)
• Eva Gerdts; K. Wachtell; Ingrid Os et al. (2004). Clinical and echocardiographic risk factors for congestive heart failure in controlled hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Study). (external link)
• K. Wachtell; Eva Gerdts; V. Palmieri et al. (2004). Does losartan improve diastolic left ventricular function beetter than atenolol during more then four years of antihypertensive treatment? The LIFE Study. (external link)
• M. Chinalli; G. Simone; J.M. Gardin et al. (2004). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE Study. (external link)
• Eva Gerdts; V. Papademetriou; K. Wachtell et al. (2004). Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Trial). (external link)
• K. Wachtell; V. Palmieri; Eva Gerdts et al. (2005). Echocardiographic determinants of new-onset atrial fibrillation in patients with hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. (external link)
• Eva M Staal; Ottar K Nygard; Per Omvik et al. (2005). Influence of hypertension on angiographic findings in patients with angina pectoris. (external link)
• H Midtbo; Eva Gerdts; IC Olsen et al. (2013). Disease Activity In Rheumatoid Arthritis Is Associated With Abnormal Left Ventricular Geometry. (external link)
• Lene Vernås Halvorsen; Stine Gognstad; Camilla Lund Søraas et al. (2022). Implications of CYP2D6 polymorphisms for therapeutic drug monitoring in patients with hypertension. (external link)
• Edda Bahlmann; Dana Cramariuc; Eva Gerdts et al. (2008). Impact of Pressure Recovery on Diagnosis of Severe Aortic Stenosis In Asymptomatic Patients. (A SEAS Substudy). (external link)
• A Rossebo; Christa Gohlke-Bärwolf; K Boman et al. (2010). Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). (external link)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Marianne Staal et al. (2006). Impact of gender on left atrial and ventricular response to asymptornatic aortic valve stenosis. The SEAS study. (external link)
• Marcello Chinali; Gerard P. Aurigemma; Peter M. Okin et al. (2010). Hypokalemi blunts left ventricular mass regression in hypertensive patients during losartan- or atenolol-based treatmend: The LIFE echo-substudy. (external link)
• Dana Cramariuc; Åshild Elseth Rieck; Giovanni Cioffi et al. (2011). Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2020). Sex-specific temporal trends in the incidence of atrial fibrillation in a large Norwegian population-based study 1986–2014. (external link)
• Eva Gerdts; E Gerdts; IC Olsen et al. (2013). Arterial Stiffness Is Associated With Abnormal Left Ventricular Geometry In Patients With Rheumatoid Arthritis. (external link)
• Einar Skulstad Davidsen; Dana Cramariuc; Øyvind Bleie et al. (2011). Increased systolic strain rate early after transcatheter aortic valve implantation. (external link)
• Mai Tone Lønnebakken; Jan Erik Nordrehaug; Eva Marianne Staal et al. (2010). Hypoperfusion by contrast echocardiography predicts coronary artery disease severity in non-ST elevation myocardial infarction. (external link)
• Dana Cramariuc; Giovanni Ciotti; Åshild E.Eidheim Elseth Rieck et al. (2008). Impact of global afterload on left ventricular myocardial contractility in asymptomatic aortic stenosis: A SEAS substudy. (external link)
• D Cramariuc; MT Lonnebakken; C Gohlke-Barwolf et al. (2012). Midwall left ventricular systolic function in asymptomatic aortic valve stenosis: is it prognostically important? The SEAS study. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). 6168 Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study. (external link)

Academic book chapter

• Eva Gerdts (1994). Hjertesykdom og svangerskap. (external link)

Doctoral thesis (PhD)

• Helga Bergljot Midtbø; Eva Gerdts (2016). Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors. (external link)
• Sahrai Saeed; Eva Gerdts (2016). Aortic stiffness and ambulatory blood pressure for cardiovascular risk assessment in young ischemic stroke patients. Insights from the Norwegian Stroke in the Young Study. (external link)
• Eva Gerdts; Hilde Halland (2019). Fitness in fatness : Associations with cardiovascular risk factors and subclinical disease. (external link)
• Dana Cramariuc; Eva Gerdts; Knut Matre (2009). Left ventricular structure and systolic function in aortic valve stenosis : influence of global left ventricular load, gender and hypertension. (external link)
• Eva Gerdts (1999). The influence of dietary salt intake on blood pressure and left ventricular mass in essential hypertension and hypertensive type-1 diabetic patients. (external link)

Conference lecture

• Eva Gerdts; Hogne Engedal; Jan Erik Nordrehaug (1995). Factors influencing the regression of left ventricular mass in men and women operated for aortic stenosis. (external link)
• JN Bella; V Palmieri; K Wachtell et al. (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men. (external link)
• V Palmieri; K Wachtell; JN Bella et al. (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects. (external link)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (external link)
• K Wachtell; V Palmieri; MH Olsen et al. (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy. (external link)
• K Wachtell; JN Bella; J Rokkedal et al. (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment. (external link)
• V Palmieri; JN Bella; K Wachtell et al. (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes. (external link)
• H Björnstad; RB Devereux; Per Omvik et al. (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy. (external link)
• Eva Gerdts; H. Bjørnstad; S. Toft et al. (1997). Hypertensive women with electrocardiographic left ventricular hypertrophy have Doppler echocardiographic indications of more impaired diastolic left ventricular function compared to men, at rest and during exercise. (external link)
• K Wachtell; JN Bella; J Rokkedal et al. (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment. (external link)
• K Wachtell; V Palmieri; MH Olsen et al. (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy. (external link)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). Long-term systolic blood pressure trajectories and incident atrial fibrillation in women and men: The Tromsø Study. (external link)
• V Palmieri; JN Bella; K Wachtell et al. (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes. (external link)
• V Palmieri; K Wachtell; JN Bella et al. (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects. (external link)
• H Björnstad; RB Devereux; Per Omvik et al. (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy. (external link)
• JN Bella; V Palmieri; K Wachtell et al. (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men. (external link)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study. (external link)
• Eva Gerdts; V. Palmieri; J. E. Otterstad et al. (2001). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the LIFE study. (external link)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1996). Factors influencing left ventricular mass in hypertense type-1 diabetic patients. (external link)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (external link)
• Eva Gerdts; Kristian Wachtell; Jennifer E. Liu et al. (2002). The impact of concomitant diabtes on changes in left ventricular structure and function during antihypertensive treatment (the LIFE study). (external link)
• Kristian Wachtell; Eva Gerdts; Vittorio Palmieri et al. (2002). Endocardial as well as midwll fractional shortening predict cardiovascular outcome in hypertension: The LIFE study. (external link)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1994). Plasma atial natriuretic peptide in salt sensitive hypertensive patients. (external link)
• Eva Gerdts; Kristian Wachtell; Per Omvik et al. (2003). Left atrial size and risk of major cardiovascular events in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial). (external link)

Editorial/Leader article

• Eva Gerdts (2012). Left atrial enlargement - A prevalent marker of hypertensive heart disease. (external link)
• Eva Gerdts; Helga Bergljot Midtbø (2023). Time to Integrate Sex in Management of Aortic Valve Stenosis. (external link)
• Helga Bergljot Midtbø; Eva Gerdts (2022). Sex disparities in blood pressure development: Time for action. (external link)
• Sahrai Saeed; Eva Gerdts (2018). Incremental prognostic value of left atrial function indices in the prediction of incident atrial fibrillation in patients with ST-elevation myocardial infarction. (external link)
• Mai Tone Lønnebakken; Eva Gerdts; Ole Martin Pedersen (2012). Femoral pseudoaneurysm with a communicating arteriovenous fistula: a complication after percutaneous coronary intervention. (external link)

Professional article

• Eva Gerdts; Maja-Lisa Løchen (2020). Utfordringer for klinisk forskning -mye mer enn Covid-19. (external link)

Letter to the editor

• Anne B. Rossebo; Eva Gerdts; Terje R. Pedersen (2009). Aortic valve stenosis. (external link)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2016). Response to: 'Disease activity and left ventricular systolic function in rheumatoid arthritis' by Giollo et al. (external link)
• Giovanni de Simone; Costantino Mancusi; Mai Tone Lønnebakken et al. (2018). Reply. (external link)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2021). Response to 'Letter to the Editor' by Rognstad et al.. (external link)
• Nikolaus Jander; Jan Minners; Franz-Josef Neumann et al. (2011). Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction". (external link)
• G Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2012). Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply. (external link)

Lecture

• Eva Gerdts (2023). Kvinner og hjertesykdom. (external link)

Non-fiction monograph

• Maja-Lisa Løchen; Eva Gerdts (2015). Kvinnehjerter En medisinsk fagbok om vanlige hjertesykdommer. (external link)
• Angela H.E.M. Maas; Eva Gerdts (2024). Manual of cardiovascular disease in women. (external link)

Popular science article

• I. Os; S Oparil; SE Kjeldsen et al. (2005). Female sex and effect of losartan versus atenolol in patients with hypertension and left ventricular hypertrophy. The LIFE study. (external link)
• D Cramariuc; AE Rieck; E.M. Staal et al. (2005). Impact of gender on left ventricular geometery and function in mild and moderate asymptomatic aortic valve stenosis. The SEAS study. (external link)

Media interview

• Siw Ch. Teigland; Maja-Lisa Løchen; Eva Gerdts (2015). 1 av 3 kvinner rammes av hjertesykdom. Nå er Marit i god hjerteform igjen. (external link)

Radio or TV participation

• En podcast om kvinnehelse Femihelse; Maja-Lisa Løchen; Eva Gerdts (2022). Kvinnehjertet Livepodcast fra Kvinnehelsehuset Arrangementet er et samarbeid mellom Kvinnehelseutvalget, Norske Kvinners Sanitetsforening og Femihelse – en podcast om kvinnehelse. (external link)

See a complete overview of publications in NVA.

FEMALE HEART project

International collaboration from 2012 with researchers at UiT The Arctic University of Norway and federico II University of Naples, Italy. Translational project involving experimental animal studies and clinical studies. The project aim to identify mechanisms for why high blood pressure is more damaging to the heart in women than in men. An annual Female Heart workshop is organized at UiB based on this collaboration. 

Hordaland Health Study - 3rd survey (HUSK3)

Focus on sex differences in how blood pressure in 40 years old women and men predicts their cardiovascular health 20 years later. A total of 2192 individuals participated during 2018-22. We are now performing detailed analyses of the 

FAT associated cardiovascular dysfunction (FATCOR)

Focus on how obesity influences cardiac and arterial function in women and men. Crossectional study of 618 individuals. The 10 year follow-up visit started in 2022 focusing on changes in blood pressure over 10 years in midlife, sex differences, confounders and underlying mechanisms. 78% of the original participants have signed up. The first part is performed at Research Unit for Health Surveys at UiB and the second part involving ergospirometric testing on threadmill at Department of Heart Disease, Haukeland University Hospital.

The IDA study

Focuses on mechanisms for uncontrolled high blood pressure in patients who are perscribed antihypertensive drugs. National Norwegian research project funded by the Norwegian Research Council. A toal of 1100 women and men were recruited and half of them turned out to have uncontrolled systolic blood pressure at ambulatory 24h blood pressure monitoring. These individuals underwent echocardiography and further evaluation. The prevalence of drug non-adherence assessed from serum concentrations was very low and similar in both sexes. Arleen Aune MD defended her PhD thesis on sex differences in cardiac organ damage and relation to drug non-adherence in 2024. See Arleen Aune, UiB.

Sex differences and hypertension in aortic stenosis

Based upon 1873 patients with aortic valve stenosis who participated in the Simvastatin Ezetimibe in Aortic Stenosis (SEAS) study. Resulted in publication of a scientific statement paper by the European Society of Cardiology on management of hypertension in patients with aortic valve stenosis. Also inspired a new line of research for sex differences in aortic, valvular and left ventricular adaptation during progression of aortic valve stenosis. Key collaborators associate professor Dana Cramariuc, UiB, PhD Edda Bahlmann, St. George's hospital, Hamburg, Germany, and Eigir Einarsen, UiB.